Search Results - "Gibb, Fraser"

Refine Results
  1. 1

    Risk of death following admission to a UK hospital with diabetic ketoacidosis by Gibb, Fraser W., Teoh, Wei Leng, Graham, Joanne, Lockman, K. Ann

    Published in Diabetologia (01-10-2016)
    “…Aims/hypothesis The aim of this study was to assess the risk of death during hospital admission for diabetic ketoacidosis (DKA) and, subsequently, following…”
    Get full text
    Journal Article
  2. 2

    Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes by Tyndall, Victoria, Stimson, Roland H., Zammitt, Nicola N., Ritchie, Stuart A., McKnight, John A., Dover, Anna R., Gibb, Fraser W.

    Published in Diabetologia (01-08-2019)
    “…Aims/hypothesis Minimal evidence supports the efficacy of flash monitoring in lowering HbA 1c . We sought to assess the impact of introducing flash monitoring…”
    Get full text
    Journal Article
  3. 3

    575-P: Improvement in HbA1c after Flash Monitoring Is Not Associated with Risk of Retinopathy Progression in Type 1 Diabetes by LINTON, KATHRYN, GIBB, FRASER W.

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…Background: Rapid improvement in HbA1c has been associated with significant short-term worsening of diabetic retinopathy. Flash monitoring (FM) is associated…”
    Get full text
    Journal Article
  4. 4

    UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD‐DTN): Best practice guide for hybrid closed‐loop therapy by Griffin, Tomás P., Gallen, Geraldine, Hartnell, Sara, Crabtree, Thomas, Holloway, Melissa, Gibb, Fraser W., Lumb, Alistair, Wilmot, Emma G., Choudhary, Pratik, Hussain, Sufyan

    Published in Diabetic medicine (01-07-2023)
    “…This best practice guide is written with the aim of providing an overview of current hybrid closed‐loop (HCL) systems in use within the United Kingdom's (UK)…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes by Gibb, Fraser W., McKnight, John A., Clarke, Catriona, Strachan, Mark W. J.

    Published in Diabetologia (01-05-2020)
    “…Aims/hypothesis We aimed to assess whether persistence of C-peptide secretion is associated with less glucose variability and fewer low-glucose events in…”
    Get full text
    Journal Article
  7. 7

    ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation by Wake, Deborah J, Gibb, Fraser W, Kar, Partha, Kennon, Brian, Klonoff, David C, Rayman, Gerry, Rutter, Martin K, Sainsbury, Chris, Semple, Robert K

    Published in European journal of endocrinology (01-08-2020)
    “…The COVID-19 pandemic is a major international emergency leading to unprecedented medical, economic and societal challenges. Countries around the globe are…”
    Get full text
    Journal Article
  8. 8

    Predictors of Nephrolithiasis, Osteoporosis, and Mortality in Primary Hyperparathyroidism by Reid, Laura J, Muthukrishnan, Bala, Patel, Dilip, Seckl, Jonathan R, Gibb, Fraser W

    “…Abstract Context Primary hyperparathyroidism (PHPT) has a prevalence of 0.86% and is associated with increased risk of nephrolithiasis and osteoporosis. PHPT…”
    Get full text
    Journal Article
  9. 9

    249-OR: Predictors of Impaired Awareness of Hypoglycemia in Adults with Type 1 Diabetes by GIBB, FRASER W., STIMSON, ROLAND H., FORBES, SHAREEN, DOVER, ANNA R.

    Published in Diabetes (New York, N.Y.) (20-06-2023)
    “…Background: Impaired awareness of hypoglycemia (IAH) is associated with a substantially increased risk of severe hypoglycemia (SH) in type 1 diabetes. Risk…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia by Baxter, Faye, Baillie, Nicola, Dover, Anna, Stimson, Roland H, Gibb, Fraser, Forbes, Shareen

    Published in PloS one (14-06-2024)
    “…Impaired awareness of hypoglycaemia (IAH) is a risk factor for severe hypoglycaemia (SH) in type 1 diabetes (T1D). Much of the IAH prevalence data comes from…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Predicting outcomes and complications following radioiodine therapy in Graves’ thyrotoxicosis by Aung, Ei Thuzar, Zammitt, Nicola N., Dover, Anna R., Strachan, Mark W. J., Seckl, Jonathan R., Gibb, Fraser W.

    Published in Clinical endocrinology (Oxford) (01-01-2019)
    “…Summary Objective Radioiodine (RAI) is an effective treatment for Graves’ thyrotoxicosis but is associated with a failure rate of 15% and may be a risk factor…”
    Get full text
    Journal Article
  16. 16

    Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2 by Stimson, Roland H, Dover, Anna R, Strachan, Mark W J, Wright, Rohana J, Forbes, Shareen, Gibb, Fraser W

    Published in Diabetic medicine (01-11-2023)
    “…We sought to assess whether conversion from Freestyle Libre to Freestyle Libre 2 (with low and high glucose alert functions) was associated with improved…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors by Gibb, Fraser W, Dixon, J Michael, Clarke, Catriona, Homer, Natalie Z, Faqehi, Abdullah M M, Andrew, Ruth, Walker, Brian R

    “…Abstract Context Aromatase deficiency causes obesity and insulin resistance in aromatase knockout mice and humans with rare mutations of the aromatase gene…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men by Gibb, Fraser W, Homer, Natalie Z. M, Faqehi, Abdullah M. M, Upreti, Rita, Livingstone, Dawn E, McInnes, Kerry J, Andrew, Ruth, Walker, Brian R

    “…Context: Deficiency of aromatase, the enzyme that catalyzes the conversion of androgens to estrogens, is associated with insulin resistance in humans and mice…”
    Get full text
    Journal Article